Pear Therapeutics Overview
- Year Founded
-
2013
- Status
-
Private
- Employees
-
218
- Latest Deal Type
-
Bankr. Admin/Reorg
Pear Therapeutics General Information
Description
Pear Therapeutics Inc is a commercial-stage healthcare company pioneering a new class of software-based medicines, sometimes referred to as Prescription Digital Therapeutics (PDTs), which use software to treat diseases directly. The company's vision is to advance healthcare through the widespread use of PDTs and to be the one-stop shop for PDTs offered by Pear and other organizations that may choose to make their products available to patients, providers, and payors via its commercial platform, known as PearConnect. It features four distinct system components, consisting of PDTs for patient use, the PearMD Clinician Dashboard, an end-to-end patient service center, and a data analytics system configured to aggregate patient engagement, adherence, and clinical outcome data.
Contact Information
Website
www.peartherapeutics.comCorporate Office
- 200 State Street
- Boston, MA 02109
- United States
Corporate Office
- 200 State Street
- Boston, MA 02109
- United States
Pear Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 13. Bankruptcy: Admin/Reorg | 07-Apr-2023 | Completed | Bankruptcy: Admin/Reorg | |||
| 12. PIPE | 03-Dec-2021 | Completed | Generating Revenue | |||
| 11. Reverse Merger | 03-Dec-2021 | Completed | Generating Revenue | |||
| 10. Later Stage VC (Series D) | 02-Mar-2021 | Completed | Generating Revenue | |||
| 9. Grant | 30-Sep-2020 | Completed | Generating Revenue | |||
| 8. Mezzanine | 07-Jul-2020 | Completed | Generating Revenue | |||
| 7. Grant | 30-Sep-2019 | Completed | Generating Revenue | |||
| 6. Later Stage VC (Series C) | 04-Jan-2019 | Completed | Generating Revenue | |||
| 5. Early Stage VC (Series B) | 28-Dec-2017 | $50M | $75M | Completed | Generating Revenue | |
| 4. Grant | 01-Jul-2017 | $334K | $25M | Completed | Generating Revenue |
Pear Therapeutics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series C | ||||||||
| Series B | ||||||||
| Series A | 24,002,981 | $0.000100 | 8% | $0.92 | $0.92 | 1x | $0.92 | 34.95% |
Pear Therapeutics Comparisons
Industry
Financing
Details
Pear Therapeutics Competitors (24)
One of Pear Therapeutics’s 24 competitors is DarioHealth, a Formerly VC-backed company based in New York, NY.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| DarioHealth | Formerly VC-backed | New York, NY | ||||
| Rightway | Venture Capital-Backed | New York, NY | ||||
| Apree Health | Private Equity-Backed | San Francisco, CA | ||||
| Health Gorilla | Venture Capital-Backed | Mountain View, CA | ||||
| Ascensia Diabetes Care | Formerly PE-Backed | Basel, Switzerland |
Pear Therapeutics Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Pear Therapeutics Patents
Pear Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| JP-2024139772-A | Automatic generation of graphical user interfaces | Pending | 27-Mar-2023 | ||
| EP-4439577-A1 | Systems and methods for sampling a prescription digital therapeutic | Pending | 27-Mar-2023 | ||
| EP-4439578-A1 | Systems and methods for the treatment of one or more indications | Pending | 27-Mar-2023 | ||
| JP-2024139773-A | Controlling access to user interfaces | Pending | 27-Mar-2023 | ||
| CA-3179823-A1 | Systems, methods, and devices for generating and administering digital therapeutic placebos and shams | Pending | 02-Jul-2020 | G16H10/20 |
Pear Therapeutics Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Pear Therapeutics Investments & Acquisitions (3)
Pear Therapeutics’s most recent deal was a Corporate Asset Purchase with Waypoint Health Innovations (Digital Therapeutic Assets). The deal was made on 16-Dec-2021.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Waypoint Health Innovations (Digital Therapeutic Assets) | 16-Dec-2021 | Corporate Asset Purchase | Other Healthcare Technology Systems | ||
| Thimble Point Acquisition | 03-Dec-2021 | Merger/Acquisition | Special Purpose Acquisition Company (SPAC) | ||
| Firsthand Technology (VR tech for pain treatment) | 07-Jan-2020 | Corporate Asset Purchase | Buildings and Property |
Pear Therapeutics ESG
Risk Overview
Risk Rating
Updated December, 11, 2023
31.36 | High Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 15,842
Rank
Percentile
Healthcare
Industry
of 623
Rank
Percentile
Medical Devices
Subindustry
of 214
Rank
Percentile
Pear Therapeutics FAQs
-
When was Pear Therapeutics founded?
Pear Therapeutics was founded in 2013.
-
Where is Pear Therapeutics headquartered?
Pear Therapeutics is headquartered in Boston, MA.
-
What is the size of Pear Therapeutics?
Pear Therapeutics has 218 total employees.
-
What industry is Pear Therapeutics in?
Pear Therapeutics’s primary industry is Other Healthcare Technology Systems.
-
Is Pear Therapeutics a private or public company?
Pear Therapeutics is a Private company.
-
What is Pear Therapeutics’s current revenue?
The current revenue for Pear Therapeutics is .
-
How much funding has Pear Therapeutics raised over time?
Pear Therapeutics has raised $396M.
-
Who are Pear Therapeutics’s competitors?
DarioHealth, Rightway, Apree Health, Health Gorilla, and Ascensia Diabetes Care are some of the 24 competitors of Pear Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
